Evidence map›Paper›PMID 20024711›Full record

ArticleAIDS care2009

The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries.

Lucy N Makoae, Carmen J Portillo, Leana R Uys, Priscilla S Dlamini, Minrie Greeff, Maureen Chirwa, Thecla W Kohi, Joanne Naidoo, Joseph Mullan, Dean Wantland and 2 more

Abstract readMulticenter Study
In one paragraph

Article in AIDS care, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Getting to 90-90-90 in paediatric HIV: What is needed?Journal of the International AIDS Society · 2015
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lucy N MakoaeNational University of Lesotho, Lesotho, South Africa. lmakoae@yahoo.com
Carmen J Portillo
Leana R Uys
Priscilla S Dlamini
Minrie Greeff
Maureen Chirwa
Thecla W Kohi
Joanne Naidoo
Joseph Mullan
Dean Wantland
Kevin Durrheim
William L Holzemer

Funding

Perceived AIDS Stigma: A Multinational African StudyR01TW006395 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOLZEMER, WILLIAM L · 2003 to 2007
$2.7M
FIC NIH HHS R01 TW006395FIC NIH HHS R01 TW06395
6 · The paper itself

Abstract

aimThis study examined the impact of taking or not taking antiretroviral (ARV) medications on stigma, as reported by people living with HIV infection in five African countries.

designA two group (taking or not taking ARVs) by three (time) repeated measures analysis of variance examined change in reported stigma in a cohort sample of 1454 persons living with HIV infection in Lesotho, Malawi, South Africa, Swaziland, and Tanzania. Participants self-reported taking ARV medications and completed a standardized stigma scale validated in the African context. Data were collected at three points in time, from January 2006 to March 2007. Participants taking ARV medications self-reported a mean CD4 count of 273 and those not taking ARVs self-reported a mean CD4 count of 418.

resultsBoth groups reported significant decreases in total HIV stigma over time; however, people taking ARVs reported significantly higher stigma at Time 3 compared to those not taking ARVs. DISCUSSION: This study documents that this sample of 1454 HIV infected persons in five countries in Africa reported significantly less HIV stigma over time. In addition, those participants taking ARV medications experienced significantly higher HIV stigma over time compared to those not taking ARVs. This finding contradicts some authors' opinions that when clients enroll in ARV medication treatment it signifies that they are experiencing less stigma. This work provides caution to health care providers to alert clients new to ARV treatment that they may experience more stigma from their families and communities when they learn they are taking ARV medications.

Indexed as

HIV InfectionsMedication AdherenceStereotypingAdultAfricaAnalysis of VarianceAnti-HIV AgentsFemaleHumansMaleAnti-HIV Agents

Identifiers

PMID20024711
PMCPMC2797125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.